CP4 - WEIGHTED AVERAGE CALCULATIONS FOR POPULATING COST-EFFECTIVENESS MODELS- HOW IGNORING THE MODEL’S CLINICAL PATHWAYS CAN SIGNIFICANTLY BIAS THE INCREMENTAL COST-EFFECTIVENESS RATIO (ICER)
Abstract
Authors
I. Van Vlaenderen K. Moeremans L. Van Bellinghen